Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

NCT06381141

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Mt. Sinai New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

NCT03981796

Conditions
Disease Attributes, Neoplasms, Pathologic Processes, +2 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
View all 169 locations
View Trial Details
Active, Not Recruiting

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

NCT04086264

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • City of Hope National Medical Center /ID# 269273 Duarte, California, United States
  • University Of California Irvine Medical Center /ID# 269275 Orange, California, United States
  • Moffitt Cancer Center /ID# 269269 Tampa, Florida, United States
  • Northwestern University- Robert H. Lurie Comprehensive Cancer Center /ID# 269642 Chicago, Illinois, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

NCT04469075

Conditions
Astrocytoma, Disease Attributes, Glioblastoma, +13 more
Locations
  • Northwestern University Evanston, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack Meridian Health Hackensack, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham - Main /ID# 151405 Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 151399 Little Rock, Arkansas, United States
  • Memorial Healthcare System /ID# 224862 Hollywood, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 161710 Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Axi-cel in CNS Lymphoma

NCT04608487

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States
  • U of Iowa Health Care Iowa City, Iowa, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions